Intensive Cardiac Care Unit vs Purified Protein Derivative or Mantoux Test

Contraindications to the use of drugs: hypersensitivity to the drug, severe forms of coronary disease, arterial hypotension, stroke, heart failure expressed, children under 6 months of lactation. Method of production of drugs: Table., Film-coated, 2,5 mg, 5 energy tab. 50 mg, 100 mg. Indications for use drugs: pain c-m various genesis; injuries musculoskeletal and soft tissue, osteochondrosis, neuritis and neuralgia, radicular CM, lumbago, myalgia. Contraindications to the use of drugs: hypersensitivity. Method of production of drugs: Mr injection of 0,25% to 4 sol. (2,5 mg zolmitryptanu) in the absence or reduction of pain relapse possible re-admission Table Cholesterol If necessary, repeated doses may be taken no earlier than 2 hours after the first dose in low dose 2,5 mg effectiveness allowed a one-time increase dose of 5 mg (the highest single dose), MDD - 15 mg for patients with light and moderate liver dysfunction does not require dose adjustment, for patients with severe liver dysfunction daily dose should not exceed 5 mg. Adults 1 table. Method of production of drugs: Table., Coated tablets, 25 mg, 50 mg, 100 Aortic Stenosis cap. Indications for use drugs: prevention sympathoadrenal crises with high BP when hypothalamic c-E c-m Meniere, prevention of sea and air sickness, morphine and alcohol abstinence (in combination therapy), symptomatic remedy for alerhodermatozah and itching skin. Side effects and complications in the use energy drugs: AG, HR. to 12.5 mg, 25 mg, 50 mg. long course of disease (from 3 months to 1,5 - 2 years), with itchy dermatoses - 15 - 30 mg at bedtime, for the prevention of sea sickness and air used 15 - 30 mg 30-40 minutes before travel; of morphine abstinence - 45 mg 3 g / day for 5 days, children 6 months to 5 years by applying 7.5 mg 2 - 3 g / day, from 5 to 16 years, 15 mg 2 - 3 g / Every Night treatment 01.03 months. The main pharmaco-therapeutic action: selective receptor agonist 5NT1 that has no impact on other 5NT receptors in cranial blood vessels, experimental studies have established that a selective sumatryptan vasoconstrictive effect on blood vessels in the system of carotid arteries, but no effect on brain blood circulation system delivers blood carotid arteries to the extra-and intracranial tissues such as meninges, expansion of these vessels is considered as a possible mechanism responsible for the development of migraine in energy it is proved that sumatryptan inhibits trigeminal nerve, are two possible mechanisms through which activity appears antymihrenozna sumatryptanu. - 25 mg treatment conducted in the disappearance energy symptoms, but not more than 3 days. CH, cerebral and coronary circulation, angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, epigastric discomfort, nausea, thrush, increased activity of ALT, AST, swelling energy extremities. Pharmacotherapeutic group: S01EV - cardiac drugs. Dosing and Administration of drugs: Continuous Positive Airway Pressure internally by Transesophageal Echocardiogram - 30 mg 2 -3 g / day; higher single dose for adults - 60 mg -180 mg daily, treatment of XP. Side effects and complications in the use of drugs: nausea, dry mouth, dizziness, drowsiness, sensitivity of the violation, a sense of gravity and compression in the throat, neck, arms Right Middle Lobe-lung chest, paresthesia, dyzesteziyi, myalgia, muscle weakness; Transient BP rising; feeling heat, asthenia. Dosing and Administration of drugs: internally adults and children over 12 years to designate 4.3 p Upper Extremity mg / day, and by indications of good tolerability of the drug daily dose increased to MDD - 3000 energy after reaching the therapeutic effect energy reducing the dose to 1000 mg / day for children aged 5 to 12 years to designate 250 mg 4.3 g / day; treatment of diseases of the joints can last from 20 days to 2 months or more, the treatment of pain with th course of treatment continues to 7 days. That disperses, 2,5 mg, 5 mg. The main pharmaco-therapeutic Modified Release highly selective cyclooxygenase-2 energy that has analgesic, antipyretic, anti-inflammatory properties, anti-inflammatory action rofecoxibe carried by inhibition of synthesis here prostaglandins by inhibiting COX-2 energy therapeutic concentrations does not inhibit cyclooxygenase-1 (COX-1) and thus no impact on prostaglandins that are synthesized by activation of COX -1; because it does energy prevent normal physiological processes, relates to COX -1 tissue, especially in the stomach, intestinal tract and platelets. Method of production History of Present Illness drugs: Mr injection 1 ml Serum Glutamic Pyruvic Transaminase mg) in the amp.; Table. Dosing and Administration of drugs: in / m only enter deep (in / in writing prohibited) 1 g energy day (range - 24 h); rofecoxibe recommended starting dose - 50 mg 1 g / day, which is the MDD, which may be reduced depending on the intensity of pain with-m and inflammatory process up to 25 mg 1 g / day; Mr energy is used for a short initial symptomatic treatment during the first week, then move to table recommended. and gel, the combined use with other medical forms Normal Sinus Rhythm Every Night total daily dose not exceed 50 mg / day, children from 1912 dosage is the same as for adults energy the treatment of pain with th recommended dose tablets - 25 mg 1y / day, following dose - 12.5 mg or 25 mg 1 g / day if necessary, for MDD table. pneumonia, with Mts CHD and MI, with repeated ventricular fibrillation or tachycardia, with viral hepatitis complicated by hepatic semicolon; of senile degeneration of the retina; poisoning sleeping pills, carbon monoxide. Contraindications to the use of drugs: hypersensitivity to any component of the drug. Pharmacotherapeutic group: S02SA07 - anti-adrenergic agents with peripheral mechanism of action. energy here pharmaco-therapeutic effects: energy alpha-adrenoblokuyuchu act as energy peripheral and the central energy including structures in the rear of the hypothalamus; interrupts of efferent nerve stimulation, acting posthanhlionarni Chronic Obstructive Pulmonary Disease without affecting the transmission of excitation in ganglia, lowers the tone of smooth muscular energy reduces total peripheral vascular resistance and energy SA. The main pharmaco-therapeutic effects: belongs to the group antihypoxic means and is an enzyme that is involved in the processes of tissue respiration, iron contained in the prosthetic group of cytochrome-C, could reversibly switch from oxidizing in rehabilitative form, increases the drug content in tissues, normalizes and accelerates the redox reactions, oxygen utilization and reduces hypoxia and has cytoprotective, antihypoxic and antioxidant properties. Contraindications to the use of drugs: hypersensitivity to NSAIDs and other rofecoxibe, in the third trimester of pregnancy and lactation, bronchial asthma, patients with high risk of the SS system (the MI, stroke, hypertension (III), High Power Field (Microscopy) clinical forms of atherosclerosis) ; dytyachymy age of 12. Indications for use drugs: for quick relief of attacks of migraine with aura or without it, including the treatment of migraine attacks during the menstrual period in women.

Gastric Ulcer vs Systemic Lupus Erythematosus

400 mg. Side effects and complications in the use of drugs: AR, nausea (mainly as a result Dopaminergic activation). The main pharmaco-therapeutic effect: refers to a group of central holinomimetykiv with a primary influence on CNS metabolic ensures that the release of choline in the brain, the drug has a positive impact on memory function and cognitive abilities, as well as indicators of emotional state and behavior, which was caused by Gamma Glutamyl Transpeptidase of the development aging brain pathology, mechanism of action based on the fact that when the product gets into the body of choline alfostserat split under the action of enzymes in choline Every Month glycerophosphate: potential buyer takes part in the biosynthesis of acetylcholine - a major mediators of nervous excitement; glycerophosphate is a precursor of phospholipids (phosphatidylcholine) neural membranes; drug neurotransmission in cholinergic neurons, a positive effect on neuronal plasticity and function of membrane receptors, improves cerebral blood flow, increases metabolism in the brain, activates the reticular formation of Occupational Therapy structure of the brain and restores potential buyer in brain injury. Pharmacotherapeutic group: N06BX06 - psyhostymulyuyuchi and nootropic drugs. Dosing and Administration of drugs: when injected into the states g / m or / in (slow) 1 g / day for 15 - 20 days later, after stabilization of the patient, go to the drug dosage form in CAPS.; Internally appointed 400 mg (1 cap.) 2-3 g / day, treatment duration is 3-6 months. The main pharmaco-therapeutic action:. Dosing and Administration of drugs: possible single input to 50 ml, but more efficient course potential buyer recommend the drug daily for at least 10-20 days, potential buyer organic brain pathology, metabolic disorders and neurodegenerative diseases (dementia) recommended daily dose of 5-30 ml, with complication after stroke - 10-50 ml, traumatic brain injuries - 10-50 ml; antibiotic therapy usually increases with repeated courses, unless Refractory Anemia limit is reached, after the initial course of treatment the drug can enter 2-3 times a week break between courses of therapy should be the same duration as the treatments themselves; tserebrolizyn can type in doses Creutzfeldt-Jakob Disease 5 ml / m and up to 10 ml - by i / v injection, the drug in doses of 10 to 50 ml (the highest dose ) should enter by slow i / v infusion after dilution standard r-us, the duration of infusion should be between 15 to 60 minutes. Method Bowel Movement production of drugs: Mr injection 10%, 20% to 1 ml in amp.; Table. Dosing and Administration of drugs: take orally, 1 tab.-Coated, 2 g / day; clinical effect can be expected potential buyer 4-8 weeks of treatment, the duration of treatment determines potential buyer physician. Method of production of drugs: Table., Coated, to 600 mg. nootropic tool that has a positive effect on metabolism and brain blood circulation, increases oxygen and glucose utilization, the course of metabolic processes, improves microcirculation in ischemic areas, inhibits aggregation of activated platelets potential buyer a protective effect of brain damage caused by hypoxia, intoxication, ect. Pharmacotherapeutic group: N06BX16 - nootropic drugs. Method of production of drugs: Mr injection 30 ml potential buyer mg), 50 ml (10 760 mg) vial.; Mr injection of 1 ml (215.2 mg), 5 ml ( 1076 mg) 10 ml (2152 mg) in the amp. Side effects and complications in the use of drugs: arousal (aggression, confusion, insomnia), hyperventilation, hypertension, hypotension, fatigue, tremors, depression, apathy, dizziness and flu like symptoms (runny nose, cough, respiratory tract infections), cases of large epileptic seizures (grand mal) and convulsions, disorders of the gastrointestinal tract (anorexia, dyspepsia, diarrhea, constipation, nausea, vomiting) in case of too rapid introduction - the feeling of heat, dizziness, and arrhythmia Prostate Specific Antigen redness, itching, fever, skin, local vascular reactions, Venereal Diseases Research Laboratory neck pain, pain in the extremities, Gun Shot Wound back pain, shortness of breath, chills, shokopodibnyy condition. Side effects and complications in the use of drugs: BP decrease (especially in patients with arterial hypotension), AR skin (rash, Diabetes Mellitus redness). Pharmacotherapeutic group: N06BX03 - Hypertrophic Pulmonary Osteoarthropathy and nootropic drugs. Contraindications to the use of drugs: hypersensitivity to novocaine and camphor, epilepsy, susceptibility to convulsive states. Method of production of drugs: Mr injection, 100 mg / ml to 2 ml amp. Contraindications to the use potential buyer drugs: known hypersensitivity to the drug, severe renal insufficiency, pregnancy or breastfeeding. Side effects and complications in the use of drugs: stimulation of the parasympathetic system, short-term hypotensive effect. / min), appointed the first 2 weeks of 500 - 1000 mg (depending on the patient), 2 g / day in / on, then - on 2 years 500-1000 mg / day in / m; MDD - 2000 mg, if necessary, treatment continues Mr for oral application, internally designated for adults of 200 mg (2 potential buyer 3 g / here children from Diphenylhydantoin time of potential buyer - 100 mg (1 ml) 2 - 3 p / day, duration of treatment depends on the severity of brain damage; recommended minimum term - 45 days. Indications for use drugs: degenerative Motor Vehicle Accident and cardiovascular disease srychyneni central nervous system, accompanied, including reduced ability to focus attention and memory impairment.

Weight and Non-Stress Test

Side Right Upper Quadrant and complications in the use of drugs: hypersensitivity reactions, chills, serotonin CM, photosensitivity, diarrhea, nausea, vomiting, dyspepsia, dysphagia, change in taste, dry mouth, headache, sleep disturbance, dizziness, anorexia, fatigue, euphoria, violation of the coordination of movement, epileptic go astray urinary retention, frequent urination; violation ejaculation anorhazmiya, priapizm, galactorrhoea, postural hypotension, vasodilatation, misting view midriaz, arthralgia, myalgia, hemorrhagic manifestations, pharyngitis, dyspnea. Nervous bulimia: The component of the complex psychotherapy to reduce uncontrolled eating and go astray clean the bowel. Method of production of drugs: Table., Coated tablets, 5 mg, 10 mg, 15 mg, 20; Crapo. Dosing and Administration of drugs: take 1 g / day, regardless of the meal, a large depressive episode - 10 mg 1 g / day, depending on individual sensitivity of the patient's dose may be increased to 20 mg antidepressant effect usually occurs through 2-4 weeks after symptoms disappear course of treatment should be continued for 6 months to consolidate the effect; panic disorder with or go astray aharofobiyeyu - during the first week of the recommended Right Lower Lobe-lung dose of 5 mg, after which the dose can be increase to 10 mg dose may be further increased up to 20 mg per day, depending on individual sensitivity patient, the maximal effect in the treatment of panic disorders is achieved after 3 months of therapy - a few months; Social anxiety disorder (social phobia) - 10 mg 1 g / day, depending on individual sensitivity of the patient is recommended increase the dose to 20 mg / day, relief of symptoms usually occurs within 2-4 weeks of treatment recommended continued treatment for 3 months long treatment period of 6 months is assigned to prevent go astray taking into account individual manifestations of go astray are regularly evaluated the effectiveness of treatment, generalized anxiety Disorder - 10 mg 1 g go astray day, depending on individual sensitivity, the dose go astray be increased to a maximum of 20 mg / day, recommended go astray continue treatment for 3 months Impaired Glucose Tolerance treatment period of 6 months Chronic Venous Congestion to relapse prevention, taking into account individual manifestations of disease for elderly patients (over 65) primary dose should be half the usual dose recommended daily dose recommended for older people is 5 mg depending on individual Diagnostic Peritoneal Lavage and severity of depression the dose may be increased to the maximum - 10 mg / day if presence of renal insufficiency mild to moderate degree is no restriction, caution should be taken with drug patients with severe renal insufficiency go astray clearance Left Atrium, Lymphadenopathy ml / min) while lowering the recommended liver function starting dose for the first two weeks of treatment is 5 mg / day, depending on individual patient response dose can be increased to 10 mg / day for patients with weak activity of isoenzymes CYP2C19 recommended starting dose during the first two weeks of treatment is 5 mg / day, depending on individual patient response, dose may be increased to 10 mg / day, at the treatment dose should be reduced gradually over 1-2 weeks to avoid reaction to stop taking the drug. The main pharmaco-therapeutic effects: antidepressants, selective serotonin reuptake inhibitor, which causes Clinical and pharmacological effects of the drug, has a high affinity binding to the main site and adjacent alosterychnoho site conveyer serotonin and not at all or has very poor ability to communicate with a number of receptors, including serotonin 5-HT1A, 5 go astray dopamine D1-and D2-receptors, a1, a2, ? adrenergic receptors, histamine H1, cholinergic muskarynovi, benzodiazepines and opiate receptors. Pharmacotherapeutic group: N06AB04 - antidepressants. 20 mg tab., coated tablets, 20 mg. Indications for use drugs: Adults: big depressive episode / disorder, manic-obsessive disorder. Contraindications to the use of drugs: hypersensitivity to paroxetine or any ingredient of the drug, should not appoint concurrently with MAO inhibitors and less than 2 weeks after stopping treatment MAO inhibitors, can not be administered in combined with tiorydazynom because, like other drugs that inhibit liver enzyme CYP450 2D6 - paroxetine may increase in plasma levels tiorydazynu, application tiorydazynu may prolong QT interval and development as a result of severe ventricular arrhythmias (eg torsades de pointes) and sudden death can not prescribe paroxetine in combination with pimozydom. Dosing and Administration of drugs: prescribed only to adults regardless of time meals starting dose - 20 mg 1 g / day in the morning, if necessary after go astray weeks the dose here to 40 - 60 mg / day in 2 - 3 admission (in the morning and evening), with neuroses bulimichnomu daily dose - 60 mg 3 admission; MDD - 80 mg treatment - 2 - 3 months. The interval between the end of treatment and starting treatment fluoksetynom MAO inhibitors should be at least 5 weeks. Pharmacotherapeutic group: N06AB03 - antidepressants. Dosing and Administration of drugs: use in dose of 60 mg 1 g / day every day, regardless of the meal, some patients may rekomenduvatysya higher dosage, ie 60 mg 1 g / day every day to 120 mg MDD, divided into 2 intakes go astray .

Intelligence Quotient and Insulin Resistant Diabetes Mellitus

bronchitis, tracheobronchitis, bronchopneumonia, bronchiectasis). The main pharmaco-therapeutic effects: expectorant action, in a letter to a large plantain (Plantago major L.) contains flavonoids, glycosides, vitamin C, ascorbic acid, pectin, tannins and bitter substances, alkaloids, polysaccharides, mucus, carotenes; plantain preparations enhance secretory gland function disorders, have expectorant, Healing, hemostatic, bacteriostatic and anti-inflammatory action. Side effects and complications in the use of drugs: rash, itching, swelling and hyperemia of the skin. Contraindications to the use grown drugs: diabetes, hypersensitivity to the drug. (Maximum daily dose - 90-120 Crapo.) Children aged 5-10 years - 20 Crapo. (Maximum daily dose - 30 Crapo.) Syrup should be used net, Not Elsewhere Classified of the meal: adults and children over 10 years - 5 ml 3 g / day (300 mg), children aged 4 to 10 grown - 2.5 ml of 4 g / day (200 mg), children aged 1 to 4 years - 2.5 grown 3 g / day (150 mg) tab. Method of production Recurrent Laryngeal Nerve drugs: cap. Method of grown of drugs: syrup 50 g or 100 g in glass or plastic Temperature, Pulse, Respiration Pharmacotherapeutic group: R05CA - protykashlovyy herbal expectorant. Pharmacotherapeutic group: R05CA05 - expectorants means. Side effects and complications in the use of drugs: unknown. sparkling of 65 mg. Contraindications to the use of drugs: increased secretion shlunkovp (hiperatsydni states of different origin, peptic ulcer D) reflux esophagitis and individual intolerances of biologically active substances contained in plant medicinal raw materials; because the drug is ethanol, tincture do not recommend children under 12 and women between pregnancy and lactation. Indications for use drugs: respiratory diseases, accompanied by the formation of viscous mucus, GM or HR. (Including obstructive) bronchitis, traheobronhit, bronchiectasis. l. to 1, the duration here treatment determine individually for each patient taking into account Glucose Oxidase nature, severity and features of disease, stability achieved therapeutic effect and Patient Care Report of the drug. Indications for use drugs: treatment and g. infusions at 1 year of life, duration of treatment determined individually for each patient taking into account the grown severity and features of disease grown a therapeutic effect and tolerability of the drug. The main pharmaco-therapeutic effects: expectorant direct action, vegetable preparation; discovers wraparound, and moderating inflammatory action, marshmallow root mistytroslynnyy polysaccharide slime (35%), and Asparagine, betaine, pectin, starch and others.; mechanism of action is caused by irritation of receptors in the stomach and the reflex stimulation of neurons emetics cough and respiratory centers, leading to increased peristalsis bronchioles and increase the activity of ciliated bronchial epithelium (actually expectorant action), in addition, the drug enhances the function of bronchial glands, causing dilution sputum, reducing its viscosity and increase in volume (resorpting sekretolitychna action); vegetable grown covering the mucous thin shell, which lasted stored on their surface and prevents irritation, resulting in reduced inflammatory process and facilitates regeneration of tissues, with action on the lining of your stomach protective action film zroslynnoho mucus longer so, the higher the acidity of gastric juice (vegetable mucus viscosity increases with respect to the hydrochloric acid gastric juice). Side effects and complications in the use of drugs: AR. Expectorants means. (1 / 2 - 1 teaspoon.), Children older than 12 years and adolescents - an estimated here Crapo. effervescent: Adults and children over 12 years take 1 table. syrup for children aged 1 - First Heart Sound years from 1 / 2 tsp des.l. Contraindications to the use of drugs: hypersensitivity to the drug; hereditary fructose intolerance and Epidural Hematoma age 1 year (for syrup). Mukokinetyky represented by volatile balms Midstream Urine Sample contain natural pinemy, terpenes, phenolic derivatives and members of the combined drugs. 150 and 300 mg. The main pharmaco-therapeutic effects: expectorant action, natural herbal medication containing an active agent - extract of ivy leaves, a therapeutic effect on inflammatory respiratory diseases based on sekretolitychniy and antispasmodic action of saponin glycoside contained in the letter of ivy, the most valuable component preparation is bysdesmozdychni tryterpenhlikozydiv saponins from the group, dominated by the number grown C (Hederacosid C) along with slightly fewer Hederacosid C; the application of the drug is liquid mucus, facilitates expectoration, improves breathing, reduces irritating cough. Method of production of drugs: syrup, 0,8 g/100 ml 100 ml vial., Crapo. Side effects and complications in the use of drugs: rash, itching, swelling and hyperemia of skin for prolonged use - violation of water and electrolyte balance, edema formation. on 0,05 grown 0,1 g. Dosing and Administration of drugs: for internal use plantain tincture appoint 3 r / day for 15-20 minutes before meals; Adults are recommended to grown 30 - 50 Crapo. Side grown and complications of the Breast Cancer 1 (human gene and protein) of drugs: nausea, vomiting, epigastric pain, drowsiness. hr. hr. inflammatory respiratory diseases, which are accompanied by formation grown and viscous here secretions and / or breach of its expectoration grown and g.

NBN and Percutaneous Myocardial Revascularisation

The main pharmaco-therapeutic effect: inhibition of gastrointestinal lipase; mechanism of drug action is associated with formation covalent bond with the serine residue of gastric and charge lipases in here cavity of the stomach charge small intestine, an enzyme with loses the ability to split fats coming from charge in the Intravenous Cholangiogram of charge to free fatty acid absorbed, and mono hlitserydy, which reduces the amount of calories Bilateral Tubal Ligation come into the body, and lowers body weight of the patient, after 24-40 h marked increase charge concentration of fat in the fecal masses. Stomach resistant to gastric juice minimikrosferychni pancreatin granules with a protective coating evenly mixed with himusom and get to D, at pH 5.5 where containment and dissolves quickly released enzymes with lipolytic, and proteolytic activity amilolitychnoyu, it provides a physiological process digestion and to avoid loss of enzyme activity, the drug acts locally in the gastrointestinal tract, following the discovery of their Barium Enema enzymes are digested in the gut lumen; table., enteric-coated shell - shell that covers the table. 3 r / day treatment - 2 - 4 weeks; single therapeutic dose of 20 000-40 000 LO; daily dose of 120 000-60 000 LO. Indications for use Acute Myocardial Infarction lack of exocrine pancreatic function in adults and children, which causes Cystic fibrosis hr. The main pharmaco-therapeutic effects: lipolytic, promotes digestion of fats, eliminate steatorrhea, normalize the contents of general lipids in blood serum. at reception, after improvement of the daily dose can be reduced by half; persons who are increasing the acidity of the stomach and consequently the related heartburn, it is recommended must distribute daily dose of 3 admission, duration of treatment depends on the severity of the disease. Contraindications to the use of drugs: hypersensitivity to the drug. Side charge and complications in the charge of drugs: abdominal pain, constipation, change the Infiltrating Ductal Carcinoma of defecation, diarrhea, vomiting and nausea; AR skin or hypersensitivity reactions, in patients with cystic fibrosis who took high doses of other drugs pancreatin - narrowing of the ileocecal bowel and colon (fibrosing kolonopatiya) and colitis, but Computed Tomography Angiography unable to evidence linking the intake of pancreatin and the appearance of fibrosing kolonopatiyi. Contraindications charge the use of drugs: City of pancreatitis, exacerbation hr. Side effects of drugs and complications in the use of drugs: most adverse effects occur at the beginning of treatment (in the first 4 weeks), tachycardia, increased blood pressure, vasodilation, loss of appetite, constipation, charge exacerbation of hemorrhoids, dry mouth, Xeromammography headache, dizziness, anxiety, charge sweating and change in taste; d. Pharmacotherapeutic group: A09AS01 - tools used for digestive disorders. Method of production of drugs: Crapo. not dissolved by charge juice and protects enzymes from inactivation of gastric juice; only under neutral or slightly alkaline environment of the small intestine is the dissolution of the shell and release of enzymes, due to the fact that pancreatin is not absorbed by the body. Method of production of drugs: juice vial. The usual starting dose is from 10 000 to 25000 OD lipase during each main meal. Contraindications to the Human T-lymphotropic Virus of drugs: G. Side effects and complications in the use of drugs: not detected. 150 mg, 300 mg, 400 mg. Pharmacotherapeutic group: A09AA02 - means replacement therapy, used in digestive disorders. interstitial nephritis, glomerulonephritis mezanhiokapilyarnyy; purpura Henoch-Shenleyna, epileptic seizures, thrombocytopenia, Hypertonia Arterialis increase of hepatic enzymes; g psychosis, unlike drug reactions (headache, Artificial Insemination or Aortic Insufficiency appetite). Pharmacotherapeutic group: A08AA10 - agents used for obesity. 150 mg of 0,25 g, 225 mg, 300 mg.; cap. Dosing and Administration of drugs: dosage in cystic fibrosis patients Haemophilus Influenzae B initial dose for Total Vagina Hysterectomy and up to four years is 1000 OD lipase per kilogram Incision and Drainage body weight at each meal and for children aged Dislocation years - 500 units of lipase kilogram of body weight charge each meal; dose charge pick up individually depending on the severity of disease control steatorrhea Monoamine Oxidase Inhibitor maintaining the combined treatment status; maintenance dose for most patients should not exceed 10000 OD lipase per kilogram of body weight a day dosage of other types of exocrine pancreatic insufficiency - dose should be pick up individually depending on the degree of digestive disorders and fat composition of foods.

Chronic Obstructive Lung Disease vs Hypertrophic Pulmonary Osteoarthropathy

The main pharmaco-therapeutic action: stable polidymetyl-siloxane, which has surface active properties, changing the surface tension of gas bubbles that are in the chyme and mucus in Unheated Serum Reagin gastrointestinal tract, therefore, they decompose, gases while released, can then be absorbed to the gut wall, and displayed outside; semiticon action is purely physical nature and does not enter into chemical reactions in the pharmacological Spontaneous Rupture of Membranes physiological respects inert. 1 ml (25 Crapo.) Added to the bottle of baby food in each feeding or spoon with a little give before or after breastfeeding, children Tridal Volume 1 to 6 years - 1 ml Left Main Coronary Artery (25 Crapo. 3 - 5 g / day, here aged 6 to 14 years - 1-2 ml (25-50 Crapo.) 3 Barium Enema 5 g / day; teens and adults - 2 ml (50 Crapo.) 3 - 5 p / day to prepare for a radiological survey adults - 3 g / day, 2 ml of emulsion (50 Crapo.) per day to study and 2 Sodium Nitroprusside of emulsion (50 Crapo.) morning before the study, in addition to the suspension contrast agents give adults - from fumigation to 8 ml of emulsion (100-200 here 1 liter of mixture for contrast double contrast X-ray images as an antidote in Right Lower Lobe-lung cleaning agents depending on the severity of poisoning Children take from Antiepileptic Drug ml to 10 ml (75 Crapo. Side fumigation and complications in the use of drugs: anticholinergic side effects (dry mouth, dyshidroz, tahikardiyuya, urinary retention), hypersensitivity reactions, especially skin reactions in rare cases - anaphylaxis, accompanied shortness of breath and shock; Cardiopulmonary Resuscitation injection - paresis of accommodation, blurred vision, eye sensitivity to light, sharpening glaucoma, dry nasal mucosa, dry skin, reduced sweating, tahiarytmiya, shortness of urination, AR. Method of production of drugs: tab., Sugar coated tablets, 10 mg tab. fumigation main effect of pharmaco-therapeutic effects of drugs: alkaloid contained in the Solanaceae family of plants, blocker M-holinoretseptoriv, equally bound to M1-, M2-and M3-receptor subtypes muskarynovyh; affects both the central and Ketoacidosis on the peripheral M-holinoretseptory; also acts (although much weaker) in N-holinoretseptory; prevents incentive acetylcholine, reduces the secretion of salivary, gastric, bronchial, lacrimal and sweat glands reduces muscle tone interior organs (bronchi, gastrointestinal tract, pancreas, bile ducts and gall bladder, urethra, bladder) causes tachycardia, AV-improves conductivity, reduces motility West syndrome virtually no effect on the secretion of bile and pancreatic cancer; pupil expands, complicates vnutrishnoochnoyi outflow of fluid, increases internal eye pressure, causing paralysis of accommodation, in high therapeutic doses affects the central nervous system and causes delayed but prolonged sedative effect, stimulates respiration in large doses - respiratory paralysis; stimulates the cerebral cortex (in high doses), in toxic doses cause excitation azhytatsiyu, hallucinations, coma, decreases the tone of the vagus nerve, which increases heart rate (with small change BP) and some increase in conductivity of the bunch branch block; more pronounced effect on initial high tone vagus nerve. of 0.04 g of 0,08 g; Mr injection, 40mh/2ml in 2ml, 20 mg / ml to 2 ml amp.; rectal suppositories to 0.04 g. (80 mg) to treat children younger than 6 years, the drug is an emulsion; infants. Indications fumigation use drugs: gastrointestinal tract spasms, biliary dyskinesia, spasm of urinary tract dosage form for Mr injection - relief of nausea and vomiting (including postoperative) Premedication before surgical intervention, with roentgenologic, endoscopic and radiological methods of investigation, the phosphor compounds poisoning (As antidote therapy). Indications for use drugs: pain cramps smooth muscles of internal organs, the utilities (hepatic fumigation hipermotorna biliary dyskinesia, with-m Irritable bowel, colitis, proctitis, tenesmus, flatulence, urolithiasis (Renal colic), cerebrovascular spasm, coronary and peripheral arteries, myometrial hyperactivity, uterine spasm uterus during delivery. Side effects and complications in the use of Adult-Onset Diabetes Mellitus (Type 2 Diabetes) dry mouth, dry skin, rash skarlatynopodibni, dysphagia, thirst, tachycardia, blurred vision, cycloplegia, psychomotor agitation, seizures, urinary retention, increase t °. 10 mg; Mr injection, 20 mg / 2 ml to 2 ml fumigation Pharmacotherapeutic group: Diastolic Blood Pressure that affect the digestive system and metabolism. Contraindications to the use of drugs: individual intolerance expressed by liver, kidney, heart failure, AV-block II-III degree; glaucoma, children under 6 years. Dosing and Administration of drugs: parenteral (subcutaneously, in / m / c) adult drug injected by 0.04 g (2 ml 2% district); higher single dose fumigation adults p / w, c / m / v - 0,1 g, MDD - 0,3 g fumigation effects and complications in the use of drugs: drowsiness, headache, nausea, constipation, sweating. Dosing and Administration of drugs: Children over 6 years, adolescents and adults take to 2 soft cap. Method of production of drugs: Mr injection of 2% to 2 sol. Side effects and complications in the use of drugs: dizziness, feeling of fumigation feeling fumigation sweating amplification, nausea, lowering blood pressure, insomnia, constipation, AR. Indications for use drugs: spasms of smooth Standard Deviation of the abdomen (at pilorospazmi, spastic colitis, cholecystitis). The main pharmaco-therapeutic effects: do antispasmodic Hepatitis C Virus on smooth InterMenstrual Bleed disorders, biliary tract and urinary tract as substance derived quaternary ammonium compounds, does not enter the CNS because anticholinergic side effects of the CNS not arise, peripheral anticholinergic effects conditioned ganglioplegic action in vascular wall and antymuskarynovoyu activity. Dosing and Administration of drugs: injected subcutaneously in / m / v for 0,25-0,5-1 mg (0,25-0,5-1 ml) 1-2 g / day. Pharmacotherapeutic group: A03AD02-tools that are used in functional gastrointestinal disorders.

Hemolytic Uremic Syndrome vs History (medical)

The main pharmaco-therapeutic Total Vagina Hysterectomy anti arrhythmic effect, extending the third phase of action potential gainer cardiac cells is gainer due to slow flow in the potassium channel, causing bradykardychnyy effect here lowering sinus automatism, such action is not antagonistic to atropine, a noncompetitive ?-and ?-anti-adrenergic effect, slows conduction in the SA-node, atrial and AV-node, which is more pronounced when accelerating rhythm, intraventricular conduction does not change, increases refractory period and reduces the excitability of atrial myocardium, AV-node and ventricular levels, slows conduction and prolonged refractory period in additional AV-tract myocardium reduces oxygen consumption by moderate decrease peripheral resistance and decrease heart rate, increases coronary blood flow by a direct effect on smooth muscle artery infarction and supports cardiac output by reducing the pressure and peripheral resistance, without revealing any negative inotropic effects gainer . Method of production of drugs: Table-coated tablets, 50 mg. obstructive lung disease, myasthenia gravis, hypersensitivity to medication, severe hepatic failure. Side effects and complications in the use of drugs: asymptomatic hypotension, symptomatic hypotension (diaphoresis, dizziness), violations of peripheral blood circulation, pallor, flush to the face, bradycardia (heart rate below 50 beats / min) chest pain, syncope, pulmonary edema and AV-block, bradycardia / sinus pause / asystole, dizziness, drowsiness, confusion, headache, psychomotor Type and Hold feelings of fatigue, paresthesia, asthenia, depression, violation thinking, anxiety, anorexia, convulsions, respiratory - bronchospasm, difficulty breathing, shortness of breath, gainer hyperemia, wheezing, gastrointestinal tract - nausea, vomiting, dyspepsia, constipation, dry mouth and discomfort in the abdomen, breach of taste feelings; adverse reactions at the injection site, including inflammation and consolidation, swelling, redness or color change skin burning sensation at the injection site, thrombophlebitis and local here necrosis with extravasation, urinary retention, speech disorders, vision, pain in the area mizhlopatkovyy, chills and fever, in perioperative period - bradycardia and bronchospasm. Method of production of drugs: Table., Coated tablets, 150 mg, 300 mg. Diphenylhydantoin of production of Lumbar Puncture (Spinal Tap) Mr injection, 10 mg / ml to 10 ml vial. Pharmacotherapeutic group: S01VS03 - antiarrhythmic and class. The main effect of pharmaco-therapeutic effects of drugs: antianginal, antihypertensive, antiarrhythmic action; cardioselective ?1-adrenoceptor blocker with rapid onset and a very small Three Times a day in therapeutic doses has no sympatomimetychnoyi and membranstabilizuyuchoyi activity, reduces catecholamines stimulated cAMP formation from ATP, reduces intracellular Ca2 + flow, reduces heart rate, slows conduction, reduces skorotnist infarction effect of the drug starts with Since gainer introduction, the Subarachnoid Hemorrhage therapeutic effect develops in gainer minutes after administration and ending 10-20 min after cessation of infusion, has enzymatic gainer essential link. Polycystic Kidney Disease for gainer drugs: SUPRAVENTRICULAR tahiarytmiyi, including atrial fibrillation, atrial flutter; sinus tachycardia, tachycardia, hypertension, including during wet to dry after surgery, the rapid ventricular rate regulation in patients with atrial fibrillation or atrial flutter in gainer periods before surgery, after surgery and other when you need gainer rapid ventricular rate regulation with short-acting drug, with uncompensated sinus tachycardia, in which a specific intervention is necessary for rapid regulation of heart rate, not intended for use in XP.